Want to see SNWV full AI Analyst Report?
SNWV Stock Chart & Stats
$31.30
$1.30(5.42%)
At close: 4:00 PM EST
$31.30
$1.30(5.42%)
Day’s Range― - ―
52-Week Range$6.11 - $46.59
Previous CloseN/A
Volume17.14K
Average Volume (3M)78.76K
Market Cap
$54.95M
Enterprise Value$159.93
Total Cash (Recent Filing)$10.78M
Total Debt (Recent Filing)$22.16M
Price to Earnings (P/E)3.6
Beta1.37
Next Earnings
Aug 18, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.76
Shares Outstanding8,598,976
10 Day Avg. Volume75,518
30 Day Avg. Volume78,757
Financial Highlights & Ratios
PEG Ratio-0.18
Price to Book (P/B)157.84
Price to Sales (P/S)5.80
P/FCF Ratio132.13
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.08
Revenue Forecast (FY)$51.35M
Bulls Say, Bears Say
Bulls Say
Strong Recent Revenue And MarginsSanuwave’s sharp top-line acceleration and very high gross margins indicate the core shock-wave technology is gaining commercial traction and pricing efficiency. Durable margin levels support reinvestment in sales, R&D and consumable rollout, strengthening earnings quality over the medium term.
Improved Cash GenerationRecent positive operating and free cash flow materially improve funding flexibility relative to prior years. Stronger cash conversion reduces reliance on external financing, helps service debt, and supports targeted commercial investments needed to scale consumable-led recurring revenue.
Growing Consumable Traction & System InstallsRising consumable usage combined with record applicator sales and expanding installed base supports a razor-and-blade recurring revenue model. Durable growth in per-system utilization increases lifetime value per customer and underpins more predictable, high-margin annuity revenue over time.
Bears Say
High Leverage And Thin EquityElevated leverage and historically thin or negative equity constrain financial flexibility and increase refinancing and solvency risk. Even with improving operations, high leverage amplifies downside during cyclical stress and can limit the company’s ability to invest or absorb reimbursement shocks.
Reseller Mix Pressuring ASPs And MarginsChannel shifts to reseller/wholesale models compress selling prices and reported revenue per unit, eroding margins and the unit economics of new-system sales. If persistent, this undermines profitability leverage from volume and forces tradeoffs between penetration and margin sustainability.
CMS Reimbursement Disruption And Secondary MarketRegulatory-driven reimbursement clawbacks and audits have created extended sales cycles, practitioner churn and a secondary market for used systems. Structural reimbursement uncertainty can permanently depress capital purchases, limiting the pace of new-system rollouts and recurring revenue growth.
Sanuwave Health News
SNWV FAQ
What was Sanuwave Health’s price range in the past 12 months?
Sanuwave Health lowest stock price was $6.11 and its highest was $46.59 in the past 12 months.
What is Sanuwave Health’s market cap?
Sanuwave Health’s market cap is $54.95M.
When is Sanuwave Health’s upcoming earnings report date?
Sanuwave Health’s upcoming earnings report date is Aug 18, 2026 which is in 30 days.
How were Sanuwave Health’s earnings last quarter?
Sanuwave Health released its earnings results on May 12, 2026. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of -$0.14 by -$0.03.
Is Sanuwave Health overvalued?
According to Wall Street analysts Sanuwave Health’s price is currently Overvalued.
Does Sanuwave Health pay dividends?
Sanuwave Health does not currently pay dividends.
What is Sanuwave Health’s EPS estimate?
Sanuwave Health’s EPS estimate is -0.03.
How many shares outstanding does Sanuwave Health have?
Sanuwave Health has 8,598,976 shares outstanding.
What happened to Sanuwave Health’s price movement after its last earnings report?
Sanuwave Health reported an EPS of -$0.17 in its last earnings report, missing expectations of -$0.14. Following the earnings report the stock price went up 18.08%.
Which hedge fund is a major shareholder of Sanuwave Health?
Currently, no hedge funds are holding shares in SNWV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sanuwave Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
SNWV Sentiment 70%
Sector Average 66%
Sector Average 66%
Insider Transactions
Sold Shares
Worth $2.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
32.00%
12-Months-Change
Fundamentals
Return on Equity
-450.56%
Trailing 12-Months
Asset Growth
20.23%
Trailing 12-Months
Company Description
Sanuwave Health
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Technical Analysis
Cerus
―
Senseonics Holdings
―
Tactile Systems Technology
―
Viemed Healthcare
―
Brainsway
―
Ownership Overview
21.99% Insiders
7.44% Mutual Funds
25.22% Other Institutional Investors
40.97% Public Companies and
Individual Investors